Add-back therapy for endometriosis in adolescents

被引：0
|
作者：
Lubianca, JN
Gordon, CM
Laufer, MR
机构：
[1] Childrens Hosp, Div Gynecol, Dept Surg, Boston, MA 02115 USA
[2] Childrens Hosp, Dept Med, Div Adolescent Young Adult Med & Endocrinol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Obstet & Gynecol, Div Reprod Endocrinol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
来源：
JOURNAL OF REPRODUCTIVE MEDICINE | 1998年 / 43卷 / 03期
关键词：
endometriosis; GnRH; GnRH agonists; adolescence; bone density; add-back therapy;
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
OBJECTIVE: To review the impact of gonadotropin-releasing hormone agonists (GnRH-as) an bone mass in adolescents and options for GnRH-a with "add-back" for long-term therapy for adolescents with endometriosis Mot responding to conventional therapy. STUDY DESIGN: Literature research. RESULTS: The use of GnRH-a plus add-back therapy has not been specifically studied in the adolescent population, and thus the ideal dosage of add-back sar steroids for adolescents has not been delineated. CONCLUSION: GnRH-a plus add-back can be considered for usage in adolescents with endometriosis who are refractory to conventional therapy, but steroids due needed to determine the ideal dosage and long-term effects.
引用
收藏
页码：164 / 172
页数：9
相关论文
共 50 条
  • [31] Steroidal 'Add-Back' therapy in patients treated with GnRH agonists - Discussion
    Genazzani, A
    Freundl, G
    Cardamakis
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1998, 45 : 30 - 30
  • [32] Dose effects of progesterone in add-back therapy during GnRHa treatment
    Cheung, TH
    Lo, KWK
    Yim, SF
    Lam, C
    Lau, E
    Haines, C
    JOURNAL OF REPRODUCTIVE MEDICINE, 2005, 50 (01) : 35 - 40
  • [33] The need for add-back with gonadotrophin-releasing hormone agonist therapy
    Studd, J
    Leather, AT
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1996, 103 : 1 - 4
  • [34] Gonadotrophin releasing hormone agonist (GnRHa)-Zoladex (Goserelin) and hormonal add-back therapy in endometriosis: a 12 month study.
    Lee, PI
    Yoon, JB
    Joo, KY
    Lee, JK
    Cho, JY
    Kim, JS
    FERTILITY AND STERILITY, 2002, 77 (02) : S23 - S23
  • [35] Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy
    Bedaiwy, Mohamed A.
    Allaire, Catherine
    Alfaraj, Sukinah
    FERTILITY AND STERILITY, 2017, 107 (03) : 537 - 548
  • [36] Effect of combined therapy GnRH-a plus add-back tibolone on endocrine hormone levels and bone loss in endometriosis patients
    Shen, Lifan
    Ma, Cailing
    Ji, Fei
    He, Yan
    Chen, Yanxia
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (11): : 4787 - 4791
  • [37] Effects of combined GnRH receptor antagonist linzagolix and hormonal add-back therapy on vaginal bleeding—delayed add-back onset does not improve bleeding pattern
    Oliver Pohl
    Line Marchand
    David Bell
    Jean-Pierre Gotteland
    Reproductive Sciences, 2020, 27 : 988 - 995
  • [38] Add-back therapy: Extending safety and efficacy of GnRH analogues in the gynecologic patient
    Surrey, ES
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1998, 45 : 31 - 34
  • [39] Extending the treatment boundaries: Zoladex and add-back
    Schlaff, WD
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1999, 64 : S25 - S31
  • [40] Long-Term Effects of Gonadotropin-Releasing Hormone Agonists and Add-Back in Adolescent Endometriosis
    Gallagher, Jenny Sadler
    Missmer, Stacey A.
    Hornstein, Mark D.
    Laufer, Marc R.
    Gordon, Catherine M.
    DiVasta, Amy D.
    JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2018, 31 (04) : 376 - 381
12345